Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001052532 | SCV001216744 | likely benign | Hyperinsulinism-hyperammonemia syndrome | 2022-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003160411 | SCV003913386 | uncertain significance | Inborn genetic diseases | 2023-02-05 | criteria provided, single submitter | clinical testing | The p.K212R variant (also known as c.635A>G), located in coding exon 4 of the GLUD1 gene, results from an A to G substitution at nucleotide position 635. The lysine at codon 212 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |